Parkside Financial Bank & Trust’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78K Buy
107
+3
+3% +$93 ﹤0.01% 1911
2025
Q4
$2.91K Hold
104
﹤0.01% 1974
2025
Q3
$3.12K Sell
104
-107
-51% -$3.02K ﹤0.01% 1871
2025
Q2
$6.04K Buy
211
+113
+115% +$3.36K ﹤0.01% 1638
2025
Q1
$3.24K Buy
98
+60
+158% +$1.96K ﹤0.01% 1760
2024
Q4
$1.09K Hold
38
﹤0.01% 1720
2024
Q3
$1.06K Buy
38
+10
+36% +$267 ﹤0.01% 1697
2024
Q2
$675 Sell
28
-6
-18% -$147 ﹤0.01% 1717
2024
Q1
$921 Hold
34
﹤0.01% 1636
2023
Q4
$944 Buy
+34
New +$883 ﹤0.01% 1636

Other funds holding ALKS

Parkside Financial Bank & Trust's ALKS Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Alkermes (ALKS) stake by 2.9% in Q1 2026, buying an estimated $93 and bringing the position to 107 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.

Parkside Financial Bank & Trust first reported a position in ALKS in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.04K in Q2 2025. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Parkside Financial Bank & Trust held 107 shares of Alkermes worth $3.78K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 3 Alkermes shares in Q1 2026, an estimated $93.
  • Alkermes made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1911 holding.
  • Parkside Financial Bank & Trust first reported a position in Alkermes in Q4 2023 and has held it in 10 quarters since.
  • Parkside Financial Bank & Trust's Alkermes position peaked at $6.04K in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.